SIRT3 has been previously demonstrated to counteract cardiac hypertrophy in primary cultures of cardiomyocytes by activating MnSOD and catalase, thereby decreasing cellular levels of ROS. The gene discussed is CAT; the disease is cardiac hypertrophy.